Skip to main content

Cranial Waveform in Normal Patients as a Result of Cardiac Cycle

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

MindRhythm
MindRhythmCA - Cupertino
1 program
Harmony HeadsetN/A1 trial
Active Trials
NCT05203393Unknown500Est. Jan 2023

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
MindRhythmHarmony Headset

Clinical Trials (1)

Total enrollment: 500 patients across 1 trials

NCT05203393MindRhythmHarmony Headset

500 "Normal" Adult Subjects Who Have Experienced no Known Brain Injury Will Participate in Collecting Data That Will Assist With the Optimization of the Diagnostic Capabilities of the Harmony in Detecting Neurologic Abnormalities.

Start: Jan 2023Est. completion: Jan 2023500 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.